Trials / Active Not Recruiting
Active Not RecruitingNCT06435884
Long-Term Follow-up of Adult With Atorpphic Scars Treated With TRTP-101
Long-Term Follow-up of Adult With Atrophic Scars Treated With TRTP-101 in Study CIC101-01
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 3 (actual)
- Sponsor
- CellinCells · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
CIC101-01-LT is a long-term follow-up study of subjects treated with TRTP-101 and will evaluate the long-term safety and efficacy of TRTP-101.
Detailed description
The long-term safety of TRTP-101 was evaluated by participants in the CIC101-01 clinical trial and followed up for 5 years for serious adverse events.
Conditions
Timeline
- Start date
- 2024-09-06
- Primary completion
- 2029-09-01
- Completion
- 2029-12-01
- First posted
- 2024-05-30
- Last updated
- 2026-03-05
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT06435884. Inclusion in this directory is not an endorsement.